CapForce Inc (CFOR)
CapForce Inc. is a healthcare company focused on biotechnology and precision medicine. The company develops and commercializes molecular microbiology solutions for serious infectious diseases in the United States and internationally. Its product portfolio includes Unyvero application cartridges and systems, Acuitas AMR Gene Panel test products, and SARS-CoV-2 test kits. CapForce also provides laboratory services, collaboration services that include funded software arrangements, license arrangement services, and listing sponsorship and consultancy services. Formerly known as OpGen, Inc., the company adopted the CapForce Inc. name in February 2026. Incorporated in 2001, CapForce is based in Clarksburg, Maryland. The listed security is common stock traded on OTC Markets under the symbol CFOR.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-CFOR
|
Not available
|
Not available
|
Not available
|
Great
|
0.0%
|
December 11, 2026
|
0.6x
|
0.5x
|
0.5x
|
41.255 M
|
6.489 M
|
4.7%
|
31.3%
|
2.0
|
-2.5%
|
